9621 Agnes Crossing, Lake Suzanneview, New Mexico Island 84604-9295.
A Major Win for Truemeds Mumbai-based healthtech startup Truemeds has just bagged a whopping $85 million (around INR 740 crore) in a Series C funding round, marking a
Mumbai-based healthtech startup Truemeds has just bagged a whopping $85 million (around INR 740 crore) in a Series C funding round, marking a huge milestone in its journey to make affordable medicines more accessible across India.
The round was backed by some of the biggest names in venture capital: Accel, Peak XV Partners, WestBridge Capital, and Info Edge Ventures.
Founded to solve one of India’s biggest pain points—the high cost of medicines—Truemeds offers affordable generic alternatives to expensive branded drugs. Its model is simple: make doctor-prescribed, high-quality medications accessible at a fraction of the cost, without compromising on quality.
The company claims to save consumers up to 70% on their medicine bills.
This latest funding round saw participation from:
These investors clearly see Truemeds as a rising star in India’s digital health and e-pharmacy sector.
Truemeds plans to use the fresh $85 million to:
The company is expected to double down on Tier 2 and Tier 3 markets—where access to affordable medicine is still a major challenge.
India’s healthtech market is booming, driven by rising digital adoption, growing health awareness, and the need for affordable medical services. Truemeds fits perfectly into this trend by offering:
With this funding, Truemeds is now well-positioned to compete with larger players like:
But Truemeds stands out with its strong focus on chronic care and cost-effective generics, which gives it a unique niche in the crowded e-pharmacy space.
The startup has hinted at future plans that may include:
With a growing customer base and deep investor backing, Truemeds seems to be aiming to become a one-stop digital health platform.
Truemeds’ $85 million Series C round isn’t just a big number—it’s a signal that India’s healthcare revolution is accelerating. With rising costs and an increasing focus on preventive care, the demand for affordable, accessible, and tech-enabled health solutions is only going to grow.
